Yokohama, Japan

Naomi Hirabayashi

This inventor holds 1 USPTO granted patent. Top assignees: Kanagawa Prefectural Hospital Organization, Nec Solution Innovators, Ltd.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Naomi Hirabayashi. Retrieved from https://idiyas.com/inventor/naomi-hirabayashi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Naomi Hirabayashi: Innovator in Nucleic Acid Research

Introduction

Naomi Hirabayashi is a prominent inventor based in Yokohama, Japan. She has made significant contributions to the field of molecular biology, particularly in the development of nucleic acid molecules. Her work focuses on understanding the pathogenic mechanisms of diseases associated with c-Met.

Latest Patents

Hirabayashi holds a patent for a nucleic acid molecule capable of binding to c-Met. This invention serves as a valuable tool for clarifying the pathogenic mechanisms of diseases caused by c-Met, as well as for the diagnosis and treatment of these conditions. The patent includes various nucleic acid molecules designated as (A1), (A2), (B1), and (B2).

Career Highlights

Throughout her career, Hirabayashi has worked with notable organizations, including NEC Solution Innovators, Ltd. and Kanagawa Prefectural Hospital Organization. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community.

Collaborations

Hirabayashi has collaborated with esteemed colleagues such as Shotaro Tsuji and Jou Akitomi. These partnerships have further enriched her research endeavors and expanded the impact of her work.

Conclusion

Naomi Hirabayashi is a trailblazer in the field of nucleic acid research, with a focus on c-Met-related diseases. Her innovative patent and collaborative efforts highlight her commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…